FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2009/091/000075 [Registered on: 06/04/2009]
Last Modified On: 24/02/2013
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study
Modification(s)  
Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study
Modification(s)  
A clinical trial to compare the effects of Misoprostol(per rectal) and Oxytocin(intravenous infusion)in reducing blood loss in women undergoing caesarean section. 
Scientific Title of Study
Modification(s)  
A randomised double- blind well controlled clinical trial to compare the efficacy and safety of rectally administered Misoprostol and Intravenous Oxytocin infusion in preventing intraoperative and postpartum blood loss in women undergoing caesarean section. 
Trial Acronym  Misoprostol,rectal,blood loss,cesarean section 
Secondary IDs if Any
Modification(s)  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Modification(s)  
Name  DrPicklu Chaudhuri 
Designation   
Affiliation   
Address  Shyamvihar,Bl-2,Fl2C
RFF-2,Raghunathpur
Kolkata
WEST BENGAL
700059
India 
Phone  03325797827  
Fax    
Email  picklu.chaudhuri@gmail.com  
 
Details of Contact Person
Scientific Query

Modification(s)  
Name  DrPicklu Chaudhuri 
Designation   
Affiliation   
Address  Shyamvihar,Bl-2,Fl2C
RFF-2,Raghunathpur
Kolkata
WEST BENGAL
700059
India 
Phone  03325797827  
Fax    
Email  picklu.chaudhuri@gmail.com  
 
Details of Contact Person
Public Query

Modification(s)  
Name  DrPicklu Chaudhuri 
Designation   
Affiliation   
Address  Shyamvihar,Bl-2,Fl2C
RFF-2,Raghunathpur
Kolkata
WEST BENGAL
700059
India 
Phone  03325797827  
Fax    
Email  picklu.chaudhuri@gmail.com  
 
Source of Monetary or Material Support
Modification(s)  
Chittaranjan ollege of obstetrics,Gynecology& child Health.37,S.P.Mukherjee Road,Kolkata-26 
 
Primary Sponsor
Modification(s)  
Name  Chittaranjan Sevasadan HospitalSPMukherjee Road Kolkata 
Address  S .P. Mukherjee Road, Kolkata 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor
Modification(s)  
Name  Address 
NIL  not applicable 
 
Countries of Recruitment
Modification(s)  
  India  
Sites of Study
Modification(s)  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrPicklu Chaudhuri  Department of G&O,Chittaranjan Sevasadan College of Obstetrics ,Gynecology&Child Health.  37,S.P.MukherjeeRoad,-700026
Kolkata
WEST BENGAL 
03325797827

picklu.chaudhuri@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Chittaranjan Sevasadan Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  Healthy women without known risk factor for Postpartum Haemorrhage are studied.,  
 
Intervention / Comparator Agent
Modification(s)  
Type  Name  Details 
Intervention  Misoprostol is given rectally after peritonium is opened during LSCS.  Dose of Misoprostol-800 microgram. 
Comparator Agent  Oxytocin infusion started immidiately after delivery of the newborn.   Dose of Oxytocin-10 units in 500 ml of Ringer Lactate solution. 
 
Inclusion Criteria
Modification(s)  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  women undergoing elective or emergency caesarean section. 
 
ExclusionCriteria 
Details  Antepartum Haemorrhage,Severe Preeclampsia,Prolonged and Obstructed labour,Hb below 8gm/dl,Multiple Pregnancy,Polyhydramnios and associated Myoma of uterus,Cardiovascular,renal ,hepatic and connective tissue disorders. 
 
Method of Generating Random Sequence
Modification(s)  
Computer generated randomization 
Method of Concealment
Modification(s)  
Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking
Modification(s)  
Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome
Modification(s)  
Outcome  TimePoints 
blood loss during operation and 8 hours postpartum and change in the hemoglobin 24 hours after delivery.  Blood loss:during operation and upto 8 hours postpartum.
Hb :predelivery and 24 hours after delivery.  
 
Secondary Outcome
Modification(s)  
Outcome  TimePoints 
need for additional uterotonic, incidence of side effects and complications, need for blood transfusion and cost of oxytocic.  Upto 24 hours postpartum. 
 
Target Sample Size
Modification(s)  
Total Sample Size="0"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial
Modification(s)  
N/A 
Date of First Enrollment (India)
Modification(s)  
01/12/2007 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial
Modification(s)  
Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Published in the Int. J of Gynecol obstet,vol 109(2010),25-29  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  
This is a randomised ,double -blind, parallel group trial comparing the widely used intravenous Oxytocin infusion and rectally adminstered Misoprostol in low risk women undergoing caesarean section with a primary outcome measure of assessing the intraoperative and postpartum blood loss over next 8 hours and change in Hb%.Secondary outcome measures ,additional oxytocic requirement,need for blood transfusion,side effects and cost -efectiveness of the drugs. 
Close